Your browser doesn't support javascript.
loading
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.
Spinner, Christoph D; Felizarta, Franco; Rizzardini, Giuliano; Philibert, Patrick; Mitha, Essack; Domingo, Pere; Stephan, Christoph J; DeGrosky, Michelle; Bainbridge, Veronica; Zhan, Joyce; Dumitrescu, Teodora Pene; Jeffrey, Jerry L; Xu, Jianfeng; Halliday, Fiona; Gan, Jianjun; Johnson, Mark; Gartland, Martin; Joshi, Samit R; Lataillade, Max.
Afiliação
  • Spinner CD; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany.
  • Felizarta F; Office of Franco Felizarta, MD, Bakersfield, California, USA.
  • Rizzardini G; Infectious Diseases, ASST Fatebenefratelli Ospedale Sacco, Milan, Italy.
  • Philibert P; School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
  • Mitha E; Infectious Disease, Hôpital Européen de Marseille, Marseille, France.
  • Domingo P; Newtown Clinical Research, Johannesburg, South Africa.
  • Stephan CJ; Infectious Diseases Unit, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
  • DeGrosky M; Infectious Diseases Unit, Universitätsklinikum Frankfurt, Frankfurt, Germany.
  • Bainbridge V; ViiV Healthcare, Branford, Connecticut, USA.
  • Zhan J; GlaxoSmithKline, Stockley Park, United Kingdom.
  • Dumitrescu TP; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Jeffrey JL; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Xu J; ViiV Healthcare, Research Triangle Park, North Carolina, USAand.
  • Halliday F; GlaxoSmithKline, Upper Providence, Pennsylvania, USA.
  • Gan J; GlaxoSmithKline, Stockley Park, United Kingdom.
  • Johnson M; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Gartland M; ViiV Healthcare, Research Triangle Park, North Carolina, USAand.
  • Joshi SR; ViiV Healthcare, Research Triangle Park, North Carolina, USAand.
  • Lataillade M; ViiV Healthcare, Branford, Connecticut, USA.
Clin Infect Dis ; 75(5): 786-794, 2022 09 14.
Article em En | MEDLINE | ID: mdl-34996113
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha